OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Squadron Capital Llc Sells 18,000 Shares

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $24.28, for a total value of $437,040.00. Following the sale, the insider directly owned 6,863,464 shares of the company’s stock, valued at approximately $166,644,905.92. This trade represents a 0.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.74, for a total value of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $25.75, for a total value of $103,000.00.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS traded down $0.47 during trading hours on Wednesday, reaching $24.03. 169,608 shares of the stock traded hands, compared to its average volume of 171,545. The company’s 50-day simple moving average is $21.11 and its two-hundred day simple moving average is $18.53. The company has a market capitalization of $627.42 million, a P/E ratio of -14.30 and a beta of 0.98. OrthoPediatrics Corp. has a 52-week low of $14.42 and a 52-week high of $26.74. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. Equities research analysts forecast that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on KIDS shares. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Piper Sandler reissued an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Needham & Company LLC raised their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, BTIG Research lifted their price objective on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a report on Thursday, August 20th. Nine equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. raised its holdings in OrthoPediatrics by 433.1% in the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares in the last quarter. Legal & General Group Plc bought a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $34,000. Northwestern Mutual Wealth Management Co. grew its position in shares of OrthoPediatrics by 5,226.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after buying an additional 2,561 shares during the period. Caption Management LLC purchased a new stake in shares of OrthoPediatrics in the 3rd quarter worth about $54,000. Finally, BNP Paribas Financial Markets increased its stake in shares of OrthoPediatrics by 60.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.